Pharmaceutical

Pirtobrutinib meets primary endpoint in CLL/SLL study Pirtobrutinib meets primary endpoint in CLL/SLL study

Promising results support global submissions and priority review by US FDA Promising results support global submissions and priority review by US FDA

Teva’s CGRP therapy becomes first approved option for children and adolescent Teva’s CGRP therapy becomes first approved option for children and adole...

Sanner, a German device CDMO and healthcare packaging specialist that has been on an expansion tear the last few years, named an interim chief executi...

The ability to inoculate young children against COVID-19 in the U.S. may be diminished this fall as the FDA weighs whether to renew the emergency gree...

The lack of an earnings call accompanying Summit’s second-quarter results came after Bloomberg last month reported that the company was engaged in hig...

With the new “Operation Access Now” program, BlinkRx claims drugmakers will be able to launch direct-to-patient sales of their products within 21 days...

Pfizer and Astellas' Padcev, combined with Keytruda, improved the survival outcomes of muscle-invasive bladder cancer patients who are ineligible for...

The FDA on Tuesday signed off on Insmed’s brensocatib to treat non-cystic fibrosis bronchiectasis (NCFBE) in adults and kids ages 12 and up. The medic...

Four years on from its original “Bent Carrot” ad, Endo has returned to the campaign for a new TV spot that looks at how a man overcame his concerns an...